patient
healthi
vaccin
vaccin
alon
complet
protect
anim
infect
diseas
environment
condit
address
exposur
infecti
agent
minim
overal
object
vaccin
vaccin
largest
possibl
number
individu
popul
risk
vaccin
individu
frequent
necessari
vaccin
infecti
agent
individu
realist
risk
exposur
subsequ
develop
diseas
kitten
younger
week
age
gener
suscept
infect
adult
cat
typic
develop
sever
diseas
repres
princip
target
popul
vaccin
matern
antibodi
interfer
common
reason
anim
immun
vaccin
also
reason
seri
vaccin
necessari
kitten
younger
week
age
vaccin
need
adult
cat
assess
least
yearli
necessari
modifi
basi
assess
risk
recommend
administr
site
parenter
vaccin
chosen
accord
guidelin
establish
american
associ
felin
practition
adopt
vaccineassoci
felin
sarcoma
task
forc
tabl
use
multipledos
vial
discourag
inadequ
mix
may
result
unequ
distribut
antigen
adjuv
possibl
result
decreas
efficaci
increas
likelihood
advers
event
iatrogen
contamin
addit
risk
panel
discourag
use
polyval
vaccin
contain
combin
felin
panleukopenia
viru
felin
felin
caliciviru
fev
exclus
opinion
base
belief
number
antigen
vaccin
increas
probabl
associ
advers
event
addit
use
polyval
vaccin
may
forc
practition
administ
vaccin
antigen
need
patient
felin
panleukopenia
caus
felin
parvoviru
fpv
viru
remain
infecti
month
year
environ
primarili
spread
via
fecalor
rout
fomit
eg
cage
food
bowl
litter
box
health
care
worker
play
import
role
transmiss
organ
clinic
sign
infect
includ
lethargi
anorexia
vomit
diarrhea
fever
profound
panleukopenia
mortal
highest
young
suscept
cat
utero
infect
fpv
common
caus
cerebellar
hypoplasia
vaccin
fpv
highli
recommend
cat
immun
felin
panleukopenia
primarili
antibodi
respons
natur
infect
vaccin
passiv
transfer
matern
antibodi
queen
kitten
matern
antibodi
may
interfer
immun
antibodi
titer
high
neonat
period
matern
antibodi
titer
gener
wane
suffici
allow
immun
week
age
immun
confer
felin
panleukopenia
vaccin
consid
excel
vaccin
anim
complet
protect
infect
clinic
diseas
serolog
challeng
exposur
data
indic
parenter
fpv
vaccin
induc
immun
sustain
least
year
initi
seri
vaccin
revaccin
year
later
cat
vaccin
frequent
everi
year
modifiedl
viru
mlv
vaccin
adjuv
inactiv
viru
vaccin
parenter
administr
well
mlv
vaccin
topic
intranas
administr
avail
effect
experiment
studi
shown
intranas
administr
canin
vaccin
puppi
less
effect
parenter
administr
overcom
matern
antibodi
interfer
ronald
schultz
phd
person
commun
like
reason
fewer
viru
particl
reach
lymphoid
tissu
product
given
intranas
compar
parenter
administr
viral
replic
lymphoid
tissu
requir
immun
mlv
parvoviru
vaccin
although
studi
perform
cat
phenomenon
may
occur
speci
caution
appropri
contempl
use
intranas
fpv
vaccin
primari
immun
kitten
especi
resid
environ
exposur
fpv
like
found
recent
cat
panleukopenialik
diseas
infect
canin
studi
show
fpv
vaccin
provid
excel
protect
fpv
also
canin
thu
canin
parvoviru
infect
concern
cat
immun
result
vaccin
fpv
vaccin
seriou
advers
event
associ
fpv
vaccin
rare
tumor
format
site
topic
administ
vaccin
report
vaccin
pregnant
queen
modifiedl
fpv
vaccin
may
possibl
result
neurolog
diseas
develop
fetus
concern
appli
kitten
vaccin
less
week
age
use
mlv
vaccin
avoid
pregnant
queen
kitten
less
month
age
iimost
often
product
approv
use
annual
given
initi
vaccin
follow
year
later
everi
year
administr
product
approv
use
everi
year
howev
vaccin
interv
must
compli
local
state
statut
ilfelv
test
recommend
vaccin
infect
cat
deriv
benefit
vaccin
product
b
bronchiseptica
vaccin
approv
use
dog
product
approv
use
dog
use
cat
mlv
modifiedl
viru
felv
felin
leukemia
viru
sc
subcutan
felin
viral
rhinotrach
caus
fcv
infect
account
case
infecti
upper
respiratori
tract
diseas
cat
virus
shed
ocular
nasal
pharyng
secret
infect
organ
transmit
cat
cat
directli
sneez
macrodroplet
indirectli
via
contamin
fomitesi
diseas
selflimit
howev
infect
cat
may
develop
chronic
oculonas
diseas
latent
infect
lifelong
cat
infect
reactiv
occur
period
stress
corticosteroid
administr
cat
infect
fcv
becom
persist
infect
shed
viru
prolong
period
month
year
although
rare
seriou
adult
cat
diseas
caus
virus
may
sever
sometim
fatal
kitten
lame
chronic
oral
inflammatori
syndrom
link
caliciviru
infect
vaccin
modifiedl
caliciviru
vaccin
risk
exposur
either
fcv
high
organ
widespread
tn
felin
popul
vaccin
fcv
highli
recommend
cat
immun
humor
cellmedi
immun
respons
natur
infect
vaccin
passiv
transfer
matern
antibodi
queen
kitten
matern
antibodi
may
interfer
induct
system
immun
respons
howev
time
kitten
week
age
matern
antibodi
titer
wane
suffici
allow
parenter
immun
topic
administ
intranas
conjunctiv
vaccin
capabl
induc
local
immun
respons
face
high
matern
antibodi
serolog
challeng
exposur
data
indic
parenter
fcv
vaccin
induc
protect
last
least
year
initi
seri
vaccin
revaccin
year
later
cat
vaccin
everi
year
regardless
rout
administr
fcv
vaccin
induc
rel
complet
protect
best
vaccin
induc
immun
respons
lessen
sever
diseas
vaccin
immun
infect
protect
sign
diseas
current
avail
fcv
vaccin
probabl
induc
protect
isol
viru
mlv
inactiv
viru
vaccin
parenter
administr
mlv
vaccin
topic
intranas
conjunctiv
administr
avail
suscept
cat
born
enter
environ
viral
upper
respiratori
tract
diseas
endem
eg
catteri
board
facil
shelter
use
topic
product
may
advantag
administr
product
kitten
young
day
age
could
consid
situat
howev
product
also
contain
modifiedl
fpv
antigen
administ
kitten
younger
week
age
advers
event
associ
vaccin
fhvl
fev
includ
mild
transient
fever
sneez
conjunct
oculonas
discharg
lame
parenter
product
pain
inject
site
sneez
conjunct
oculonas
discharg
ulcer
nasal
philtrum
believ
occur
frequent
vaccin
licens
topic
use
tumor
format
site
topic
administ
vaccin
report
rabi
transmit
mainli
bite
wound
infect
mammal
cat
dog
develop
rabi
unit
state
although
rel
resist
rabi
speci
serv
potenti
sourc
infect
human
be
treatment
ineffect
cat
develop
clinic
sign
attempt
high
potenti
zoonot
infect
instanc
suspect
known
rabi
viru
infect
must
report
local
health
depart
offici
proper
precaut
quarantin
procedur
outlin
local
regul
describ
compendium
anim
rabi
prevent
control
follow
although
vaccineassoci
sarcoma
report
develop
associ
administr
varieti
vaccin
current
data
suggest
frequent
associ
administr
felin
leukemia
viru
felv
vaccin
adjuv
rabi
viru
vaccin
inflammatori
reaction
commonli
observ
site
adjuv
rabi
viru
vaccin
administ
concern
arisen
regard
possibl
associ
reaction
vaccineassoci
sarcoma
except
recent
approv
canarypox
virusvector
recombin
felin
rabi
viru
vaccin
purevax
felin
rabi
vaccin
merial
limit
iselin
nj
rabi
viru
vaccin
current
market
contain
adjuv
rat
inflamm
induc
recombin
product
seem
whether
use
vaccin
associ
reduc
likelihood
vaccineassoci
sarcoma
format
cat
yet
known
recombin
product
current
licens
annual
administr
rabi
viru
vaccin
highli
recommend
cat
requir
law
state
municip
manufactur
requir
us
depart
agricultur
establish
mean
experiment
challeng
exposur
studi
minimum
durat
immun
rabi
viru
vaccin
sell
product
approv
use
everi
year
everi
year
avail
statut
govern
administr
rabi
viru
vaccin
vari
consider
throughout
unit
state
veterinarian
compli
legal
requir
area
felv
infect
domest
cat
throughout
world
transmiss
transfer
viru
saliva
nasal
secret
result
prolong
intim
contact
eg
mutual
groom
bite
share
food
water
utensil
viru
may
also
transmit
transfus
blood
infect
cat
utero
milk
exposur
viru
persist
environ
fomit
aerosol
secret
effici
mean
viral
transmiss
clinic
sign
felv
infect
primarili
relat
neoplasia
anemia
diseas
result
immunosuppress
kitten
suscept
infect
resist
increas
matur
experiment
data
demonstr
kitten
younger
week
age
suscept
infect
cat
older
rel
resist
cat
greatest
risk
includ
outdoor
cat
freeroam
pet
stray
cat
feral
cat
also
risk
cat
resid
open
multiplecat
environ
cat
live
felvinfect
cat
cat
resid
household
unknown
felv
statu
decis
vaccin
individu
cat
felv
infect
base
cat
age
risk
exposur
vaccin
felv
recommend
cat
risk
exposur
ie
cat
restrict
close
felvneg
indoor
environ
especi
younger
month
age
vaccin
recommend
cat
minim
risk
exposur
especi
older
month
age
abil
particular
vaccin
brand
induc
immun
respons
suffici
resist
persist
viremia
vari
studi
protect
induc
vaccin
prevent
exposur
infect
cat
remain
singl
best
way
prevent
felv
infect
vaccin
felv
diminish
import
test
cat
identifi
virem
critic
import
virem
cat
contact
cat
especi
younger
month
age
result
felv
infect
statu
cat
advers
event
associ
vaccin
felv
includ
local
swell
pain
transient
lethargi
fever
postvaccin
granuloma
format
although
vaccineassoci
sarcoma
report
develop
associ
administr
vaccin
current
data
suggest
frequent
associ
administr
felv
vaccin
adjuv
rabi
viru
vaccin
vaccin
deem
appropri
annual
revaccin
recommend
cat
test
felv
infect
initi
vaccin
possibl
expos
felv
sinc
vaccin
enzymelink
immunosorb
assay
prefer
screen
test
indirect
immunofluoresc
assay
prefer
confirmatori
individu
confirm
infect
felv
need
receiv
felv
vaccin
segreg
uninfect
cat
chlamydia
psittaci
bacteri
pathogen
conjunctiva
respiratori
tract
cat
transmiss
direct
cattocat
contact
fomit
transmiss
less
like
organ
unstabl
environ
serou
conjunct
may
initi
affect
one
eye
common
clinic
sign
sneez
nasal
discharg
may
develop
develop
usual
mild
clinic
sign
usual
evid
day
infect
resolv
appropri
antimicrobi
treatmenu
isol
rate
report
rang
cat
without
sign
respiratori
tract
diseas
approxim
cat
concurr
upper
respiratori
tract
diseas
highest
rate
infect
report
cat
week
month
age
immun
confer
c
psittaci
vaccin
similar
confer
fcv
vaccin
vaccin
protect
sever
clinic
diseas
infect
frequenc
advers
system
event
associ
c
psittaci
vaccin
higher
associ
commonli
use
vaccin
reaction
includ
lethargi
depress
anorexia
lame
fever
day
vaccin
sign
diseas
associ
c
psittaci
infect
compar
mild
respond
favor
treatment
advers
event
associ
use
c
psittaci
vaccin
greater
concern
advers
event
associ
use
mani
product
routin
vaccin
c
psittaci
infect
recommend
vaccin
may
consid
cat
multiplecat
environ
infect
associ
clinic
diseas
confirm
vaccin
deem
appropri
annual
revaccin
recommend
felin
coronavirus
fcov
vari
consider
pathogen
potenti
histor
group
two
biotyp
felin
enter
coronavirus
typic
caus
subclin
mild
enter
infect
felin
infecti
periton
fip
virus
caus
fip
current
pip
virus
believ
gener
mutant
variant
felin
enter
coronavirusinfect
cat
fcov
widespread
felin
popul
worldwid
seroposit
rate
highest
crowd
multiplecat
environmentsi
transmiss
viru
mainli
via
fecalor
rout
environ
fcov
infect
endem
eg
multiplecat
environ
cat
shed
fcov
stool
given
time
infect
cat
remain
healthi
although
usual
ultim
develop
fip
affect
cat
rare
surviv
regardless
treatment
kitten
often
affect
fip
diseas
reportedli
develop
cat
age
genet
predisposit
suggest
higher
diseas
incid
certain
line
consider
controversi
surround
abil
current
avail
fip
vaccin
primucellfip
pfizer
anim
health
exton
pa
prevent
diseas
studi
demonstr
protect
diseas
other
show
littl
benefit
vaccin
antibodydepend
enhanc
diseas
vaccin
demonstr
experiment
challeng
exposuj
e
uncertain
whether
antibodydepend
enhanc
occur
natur
set
discrep
studi
result
probabl
attribut
differ
test
methodolog
eg
strain
dose
challeng
viru
genet
predisposit
test
anim
protect
diseas
demonstr
anim
vaccin
younger
week
age
kitten
born
rear
environ
fco
v
infect
endem
infect
reach
age
l
instanc
vaccin
infect
cat
proven
benefici
time
evid
vaccin
induc
clinic
relev
protect
use
recommend
cani
infect
recommend
time
write
product
independ
evalu
efficaci
base
studi
conduct
manufactur
reason
consid
vaccin
adjunct
treatment
individu
infect
cat
month
age
older
hasten
resolut
clinic
sign
vaccin
induc
immun
respons
acceler
lesion
resolut
number
infecti
fungal
spore
produc
vaccin
may
reduc
well
thu
reason
consid
vaccin
one
compon
comprehens
treatment
program
multiplecat
environ
cani
infect
endem
nonetheless
abil
product
hasten
elimin
endem
infect
environ
evalu
revaccin
interv
stipul
label
major
advers
event
reportedli
associ
use
product
pain
temporari
hair
loss
format
steril
abscess
granuloma
vaccin
site
bordetella
bronchiseptica
small
aerob
gramneg
coccobacillu
long
recogn
respiratori
tract
pathogen
sever
speci
anim
natur
rout
transmiss
cat
believ
via
aerosol
intranas
rout
experiment
challeng
exposur
studi
shown
b
bronchiseptica
act
primari
pathogen
cat
inocul
specificpathogenfre
kitten
result
selflimit
diseas
character
variabl
degre
fever
nasal
ocular
discharg
sneez
induc
spontan
cough
pulmonari
rale
submandibular
bronchopneumonia
associ
natur
occur
b
bronchiseptica
infect
report
kitten
adult
cat
factor
includ
nutrit
statu
overcrowd
coinfect
agent
fev
suboptim
hygien
may
influenc
outcom
exposur
seropreval
survey
suggest
exposur
organ
common
infect
rate
vari
popul
popul
highest
rate
seroposit
often
found
among
cat
rescu
shelter
multiplecat
household
especi
histori
respiratori
tract
diseas
lowest
rate
found
among
cat
household
cat
histori
respiratori
tract
diseas
similarli
isol
rate
vari
b
bronchiseptica
isol
oropharynx
asymptomat
cat
distal
trachea
asymptomat
cat
shelter
lousiana
recent
survey
cat
unit
kingdom
none
household
cat
found
infect
cat
breed
coloni
cat
rescu
shelter
found
carri
organ
survey
healthi
cat
cat
respiratori
tract
diseas
test
posit
organ
addit
find
strong
posit
associ
oropharyng
isol
b
bronchiseptica
resid
household
contain
dog
recent
histori
respiratori
tract
diseas
definit
diagnosi
diseas
associ
b
bronchiseptica
infect
may
difficult
part
sign
infect
often
mimic
associ
fhvl
fev
infect
isol
b
bronchiseptica
cat
respiratori
tract
diseas
support
diagnosi
carriag
organ
asymptomat
cat
preclud
establish
direct
causeandeffect
relat
resolut
diseas
appropri
chosen
antimicrobi
medic
might
suggest
caus
role
b
bronchiseptica
selflimit
natur
mani
case
viral
upper
respiratori
tract
diseas
prevent
attribut
diseas
resolut
sole
antimicrobi
treatment
vaccin
protexbb
intervet
prevent
diseas
caus
infect
b
bronchiseptica
recent
licens
product
contain
live
reducedvirul
cultur
b
bronchiseptica
licens
administr
via
intranas
rout
cat
week
age
older
efficaci
vaccin
independ
evalu
howev
studi
conduct
manufactur
gain
vaccin
licensur
vaccin
specificpathogenfre
cat
experienc
less
sever
sign
diseas
unvaccin
control
expos
challeng
week
vaccin
similar
result
obtain
kitten
expos
challeng
hour
vaccin
write
studi
evalu
durat
protect
induc
vaccin
complet
revaccin
interv
yet
stipul
label
routin
use
vaccin
recommend
reason
consid
vaccin
cat
enter
resid
multiplecat
environ
eg
shelter
catteri
board
facil
diseas
associ
b
bronchiseptica
infect
confirm
abil
product
reduc
preval
infect
sever
diseas
environ
evalu
howev
infect
cat
protozoan
giardia
lamblia
associ
acut
chronic
gastrointestin
diseas
rang
sever
subclin
sever
infect
cat
shed
cyst
intermitt
diagnosi
g
lamblia
infect
often
cumbersom
usual
requir
multipl
fecal
examin
sever
method
diagnosi
avail
includ
examin
fecal
smear
zinc
sulfat
centrifug
method
use
enzymelink
immunosorb
assay
test
fece
current
approv
treatment
method
cat
although
treatment
commonli
control
sign
diseas
uncertain
clear
infect
treatment
effect
highli
variabl
resist
organ
commonli
encount
g
lamblia
transmit
via
fecalor
rout
cyst
may
ingest
contamin
water
direct
cattocat
transmiss
especi
crowd
environ
eg
mutual
groom
exposur
contamin
litter
box
consum
prey
giardiasi
recogn
zoonot
diseas
role
cat
transmiss
organ
well
establish
vaccin
recent
licens
us
depart
agricultur
felovax
giardia
fort
dodg
anim
health
aid
prevent
diseas
associ
c
lamblia
infect
reduct
sever
shed
cyst
vaccin
compos
quantifi
homo
gena
ted
chemic
inactiv
g
lamblia
trophozoit
contain
adjuv
commonli
found
felin
product
manufactur
differ
adjuv
manufactur
canin
product
vaccin
approv
use
cat
week
age
older
time
write
vaccin
independ
evalu
efficaci
studi
conduct
manufactur
gain
vaccin
licensur
vaccin
statist
signific
reduct
sever
clinic
sign
diarrhea
durat
cyst
shed
preval
infect
percentag
cat
trophozoit
end
trial
compar
control
anim
protect
demonstr
persist
least
year
vaccin
routin
use
vaccin
recommend
vaccin
less
sever
clinic
diseas
shed
cyst
shorter
time
reason
consid
vaccin
part
comprehens
control
program
environ
exposur
g
lamblia
clinic
signific
parasit
exposur
ongo
revaccin
annual
interv
recommend
vaccin
may
shed
cyst
subsequ
c
lamblia
exposur
thu
proper
hygien
sanit
practic
implement
even
vaccin
cat
abil
product
aid
hasten
elimin
endem
infect
multiplecat
environ
evalu
